Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Fallon

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|March 1, 1994
Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude miceS L Gibson, T H Foster, R H Feins, et al.
Cancer|June 20, 2001
Low bone mineral density in hormone-naïve men with prostate carcinomaM R Smith, F J McGovern, M A Fallon, et al.
Caries Research|October 28, 2005
A mouse caries model and evaluation of aqp5-/- knockout miceD J Culp, R Q Quivey, W H Bowen, et al.
Physiological Genomics|September 2, 2004
The gene encoding mouse Muc19: cDNA, genomic organization and relationship to SmgcD J Culp, L R Latchney, M A Fallon, et al.
Physiological Genomics|July 9, 2003
The sld mutation is specific for sublingual salivary mucous cells and disrupts apomucin gene expressionM A Fallon, L R Latchney, A R Hand, et al.
Annals of Clinical and Laboratory Science|January 1, 1994
The role of flow cytometry in the diagnosis of lymphoma: a critical analysisE E Morse, H T Yamase, B R Greenberg, et al.
The New England Journal of Medicine|September 29, 2001
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancerM R Smith, F J McGovern, A L Zietman, et al.
The New England Journal of Medicine|December 21, 1995
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working PartyJ J Eron, S L Benoit, J Jemsek, et al.
Transplantation|January 27, 1995
Prevention of chronic rejection and graft arteriosclerosis by tolerance inductionM S Orloff, E M DeMara, M L Coppage, et al.
AIDS (London, England)|August 1, 1996
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patientsD R Kuritzkes, J B Quinn, S L Benoit, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|March 1, 1994
Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude miceS L Gibson, T H Foster, R H Feins, et al.
Cancer|June 20, 2001
Low bone mineral density in hormone-naïve men with prostate carcinomaM R Smith, F J McGovern, M A Fallon, et al.
Caries Research|October 28, 2005
A mouse caries model and evaluation of aqp5-/- knockout miceD J Culp, R Q Quivey, W H Bowen, et al.
Physiological Genomics|September 2, 2004
The gene encoding mouse Muc19: cDNA, genomic organization and relationship to SmgcD J Culp, L R Latchney, M A Fallon, et al.
Physiological Genomics|July 9, 2003
The sld mutation is specific for sublingual salivary mucous cells and disrupts apomucin gene expressionM A Fallon, L R Latchney, A R Hand, et al.
Annals of Clinical and Laboratory Science|January 1, 1994
The role of flow cytometry in the diagnosis of lymphoma: a critical analysisE E Morse, H T Yamase, B R Greenberg, et al.
The New England Journal of Medicine|September 29, 2001
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancerM R Smith, F J McGovern, A L Zietman, et al.
The New England Journal of Medicine|December 21, 1995
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working PartyJ J Eron, S L Benoit, J Jemsek, et al.
Transplantation|January 27, 1995
Prevention of chronic rejection and graft arteriosclerosis by tolerance inductionM S Orloff, E M DeMara, M L Coppage, et al.
AIDS (London, England)|August 1, 1996
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patientsD R Kuritzkes, J B Quinn, S L Benoit, et al.
Pageof 3